Published in Transplantation on May 15, 2001
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18
Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med (2006) 1.07
Development of hepatic tissue engineering. Pediatr Surg Int (2009) 0.82
Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering. J Biomater Appl (2012) 0.75
Expression, purification and bioactivity of human augmenter of liver regeneration. World J Gastroenterol (2006) 0.75
Promoting the recovery of injured liver with poly (3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) scaffolds loaded with umbilical cord-derived mesenchymal stem cells. Tissue Eng Part A (2014) 0.75
Tissue engineering. Science (1993) 19.65
A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials (2003) 3.63
Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics (1989) 3.38
Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg (1997) 2.93
Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology (2001) 2.71
Pure laparoscopic full-left living donor hepatectomy for calculated small-for-size LDLT in adults: proof of concept. Am J Transplant (2013) 2.36
Bioengineered teeth from cultured rat tooth bud cells. J Dent Res (2004) 2.31
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials (1996) 2.27
Basiliximab monotherapy following B-cell lymphoma after pediatric liver transplantation and anti-CD20 therapy. Pediatr Transplant (2003) 2.03
The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res (2007) 1.93
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77
Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg (1998) 1.76
Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng (2000) 1.71
Tissue engineering of complex tooth structures on biodegradable polymer scaffolds. J Dent Res (2002) 1.61
Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell (1994) 1.61
Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials (1993) 1.57
Is radical surgery in locally advanced gallbladder carcinoma justified? Am J Gastroenterol (1995) 1.54
Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr (1985) 1.52
Tissue-engineered growth of cartilage: the effect of varying the concentration of chondrocytes seeded onto synthetic polymer matrices. Int J Oral Maxillofac Surg (1994) 1.52
Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51
Hemostasis with the ultrasonically activated scalpel. Effective substitute for electrocautery in surgical patients with pacemakers. Surg Endosc (1999) 1.51
A polymer foam conduit seeded with Schwann cells promotes guided peripheral nerve regeneration. Tissue Eng (2000) 1.48
EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol (2004) 1.47
Tissue engineering: the challenges ahead. Sci Am (1999) 1.45
Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg (1991) 1.44
Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44
Hemobilia: presentation, diagnosis, and management. Am J Gastroenterol (1994) 1.43
Standard liver volume in the Caucasian population. Liver Transpl Surg (1999) 1.43
Tissue engineering: current state and prospects. Annu Rev Med (2001) 1.42
Atlas of esophageal atresia. J Pediatr Surg (1976) 1.41
Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transplant Proc (1997) 1.41
Hilar traumatic neuroma after liver transplantation. Transpl Int (1997) 1.41
First experience with basiliximab in pediatric liver graft recipients. Pediatr Transplant (2001) 1.40
Systemic effects and side effects of interstitial techniques used in liver tissue. J Am Coll Surg (1999) 1.39
Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials (2004) 1.32
Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg (2001) 1.32
Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science. J Cell Mol Med (2007) 1.31
Hereditary multiple atresias of the gastrointestinal tract: report of a case and review of the literature. J Pediatr Surg (1998) 1.29
Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg (1998) 1.29
Congenital diaphragmatic hernia--a tale of two cities: the Boston experience. J Pediatr Surg (1997) 1.28
Executive functioning in preschool children: performance on A-not-B and other delayed response format tasks. Brain Cogn (1999) 1.26
Fetal diaphragmatic hernia: ultrasound diagnosis and clinical outcome in 38 cases. J Pediatr Surg (1989) 1.25
Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng (1991) 1.24
Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg (1995) 1.24
Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study. Hepatology (1996) 1.23
A hundred patients with vertical rectus abdominis myocutaneous (VRAM) flap for pelvic reconstruction after total pelvic exenteration. Int J Colorectal Dis (2014) 1.19
Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Pediatr Psychol (2001) 1.17
Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials (1996) 1.16
Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation (2000) 1.16
Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol (1992) 1.16
A new approach to tissue engineering of vascularized skeletal muscle. J Cell Mol Med (2006) 1.15
Formation of phalanges and small joints by tissue-engineering. J Bone Joint Surg Am (1999) 1.15
Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg (1999) 1.15
Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation (1996) 1.14
Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J Biomed Mater Res (1999) 1.13
Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng (2004) 1.13
Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neointestine. J Pediatr Surg (1998) 1.11
Living donor for liver transplantation. Hepatology (1994) 1.11
Living related liver transplantation: 36 cases at the University of Hamburg. Transplant Proc (1994) 1.10
FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun (2001) 1.10
Surgical treatment of chronic pancreatitis and quality of life after operation. Surg Clin North Am (1999) 1.08
Experimentally induced congenital diaphragmatic hernia in rats. J Pediatr Surg (1990) 1.08
Embryology of bladder exstrophy. J Pediatr Surg (1988) 1.08
Prevascularization of porous biodegradable polymers. Biotechnol Bioeng (1993) 1.08
[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres]. Z Gastroenterol (2011) 1.07
Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med (2006) 1.07
Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg (2000) 1.07
In vitro organogenesis of liver tissue. Ann N Y Acad Sci (1997) 1.07
Selection of the living liver donor. Transplantation (1995) 1.07
New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng (2000) 1.06
Cardiovascular physiology during fetal development and implications for tissue engineering. Tissue Eng (2001) 1.06
Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation (1996) 1.06
Hepatocytic gene expression in cultured rat mesenchymal stem cells. Transplant Proc (2005) 1.05
Dynamic seeding and in vitro culture of hepatocytes in a flow perfusion system. Tissue Eng (2000) 1.05
Biodegradable sponges for hepatocyte transplantation. J Biomed Mater Res (1995) 1.05
Is there still a need for living-related liver transplantation in children? Ann Surg (2001) 1.04
New procedures to assess executive functions in preschool children. Clin Neuropsychol (2001) 1.04
Injectable cartilage. Plast Reconstr Surg (1995) 1.03
Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng (2000) 1.03
Transplantation of hepatocytes using porous, biodegradable sponges. Transplant Proc (1994) 1.01
Delayed repair and preoperative ECMO does not improve survival in high-risk congenital diaphragmatic hernia. J Pediatr Surg (1992) 1.01
De novo cartilage generation using calcium alginate-chondrocyte constructs. Plast Reconstr Surg (1996) 1.01
Hepatic retransplantation in New England--a regional experience and survival model. Transplantation (1993) 1.01
Bioengineered dental tissues grown in the rat jaw. J Dent Res (2008) 1.01
Temporomandibular joint disc replacement made by tissue-engineered growth of cartilage. J Oral Maxillofac Surg (1994) 1.01
Cartilage engineered in predetermined shapes employing cell transplantation on synthetic biodegradable polymers. Plast Reconstr Surg (1994) 1.01